Menu Back to 14th-DIA-Japan-Annual-Meeting-2017

Overview

Flyer will be available soon!

 

Call for Abstract Now!

Submit your abstract for DIA Japan Annual Meeting 2017! For the details, please refer to the flyer on this call for abstract. To submit, please visit our "Abstract" webpage.  Deadline is April 30.

Program Committee

  • Yasuhiro  Fujiwara, MD, PhD
    Yasuhiro Fujiwara, MD, PhD Director General, Strategic Planning Bureau
    National Cancer Center, Japan
  • Akiko  Ikeda, RPh
    Akiko Ikeda, RPh Senior Manager, Policy Intelligence Dept., Integrated Market Access Division
    Janssen Pharmaceutical K.K., Japan
  • Yoshikata  Furuya, MSc
    Yoshikata Furuya, MSc Director, Vaccine Policy, Health Policy
    MSD K.K., Japan
  • Natsuko  Hamada
    Natsuko Hamada Regulatory Scientist, Therapeutic Area Regulatory, Japan Regulatory Affairs
    Eli Lilly Japan K.K., Japan
  • Mitsuo  Hayashi, MSc
    Mitsuo Hayashi, MSc Director, Clinical Enablement
    MSD K.K., Japan
  • Kanji  Hirai, RPh
    Kanji Hirai, RPh Director, Regulatory Policy & Intelligence, Regulatory Affair Area, Japan Dvlpmt
    MSD K.K., Japan
  • Akihiro  Hirakawa, PhD
    Akihiro Hirakawa, PhD Project Associate Professor, Department of Biostatistics and Bioinformatics
    Graduate School of Medicine, The University of Tokyo, Japan
  • Ayaka  Hiramatsu, MPharm
    Ayaka Hiramatsu, MPharm Reviewer Office of New Drug2
    Pharmaceuticals and Medical Devices Agency, Japan
  • Shinzo  Hiroi, MPH, RPh, PMP
    Shinzo Hiroi, MPH, RPh, PMP Associate Director, Global Medical Affairs - Japan
    Takeda Pharmaceutical Company Limited, Japan
  • Takahiro  Inoue
    Takahiro Inoue Director, Division of Drug Research Promotion
    Japan Agency for Medical Research and Development (AMED), Japan
  • Kazuhiko  Ishida, MS, RPh
    Kazuhiko Ishida, MS, RPh Associate Director, Pharmacovigilance
    Astellas Pharma Inc., Japan
  • Koji  Iwasaki, PhD
    Koji Iwasaki, PhD Director, Strategic Medical Research Planning, Global Medical Affairs-Japan
    Takeda Pharmaceutical Company Limited, Japan
  • Masashi  Kaichi
    Masashi Kaichi
    Japan Agency for Medical Research and Development (AMED), Japan
  • Kazuhiro  Kanmuri, PhD
    Kazuhiro Kanmuri, PhD Japan Development Leader, CV/MET, Clinical Research
    Pfizer Japan Inc., Japan
  • Chika  Kiryu, DVM, PhD
    Chika Kiryu, DVM, PhD Headquarters of Clinical Development, Department of Clinical Management
    Otsuka Pharmaceutical Co., Ltd., Japan
  • Nobuhiro  Koga, MBA, PMP
    Nobuhiro Koga, MBA, PMP Director
    PAREXEL International Inc., Japan
  • Yoshiko  Komuro, PhD
    Yoshiko Komuro, PhD Deputy Review Director, Office of New Drug II
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Kaori  Muto, PhD
    Kaori Muto, PhD Professor, Department of Public Policy, The Institute of Medical Science
    The University of Tokyo, Japan
  • Goshi  Ozawa, MS
    Goshi Ozawa, MS President
    Real Discovery Outdoors Co.,Ltd., Japan
  • Rie  Matsui, RPh
    Rie Matsui, RPh Director, Regional Labeling Head for Asia, International Labeling Group
    Pfizer Japan Inc., Japan
  • Takashi  Sato, MSc, PMP
    Takashi Sato, MSc, PMP Manager, Development Administration Group, Development Coordination Department
    Kyowa Hakko Kirin Co., Ltd., Japan
  • Yumi  Sugiura, MRCP
    Yumi Sugiura, MRCP Central Monitor, Global Data Strategies and Solutions
    Bristol-Myers Squibb K.K., Japan
  • Atsushi  Tsukamoto, PhD, MSc
    Atsushi Tsukamoto, PhD, MSc Senior Director, R&D Strategy & Coordination Gr., R&D Planning & Management Dept
    Daiichi Sankyo Co., Ltd., Japan
  • Keiko  Tsumori
    Keiko Tsumori Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Hisashi  Urushihara, DrPH, MS
    Hisashi Urushihara, DrPH, MS Professor, Div. of Drug Development and Regulatory Science, Faculty of Pharmacy
    Keio University, Japan
  • Koichiro  Yuji, MD, PhD, FACP
    Koichiro Yuji, MD, PhD, FACP Project Associate Professor, Project Div. of Int'l Advanced Medical Research
    Institute of Medical Science, The University of Tokyo, Japan
  • Junichi  Nishino, MSc, RPh
    Junichi Nishino, MSc, RPh Head, RA Functions Department, GDD Function & Regulatory Office in Japan
    Novartis Pharma K.K., Japan
  • Yoshihiko  Ono, RPh
    Yoshihiko Ono, RPh Executive Director, Head of Regulatory Affairs, Japan Development
    MSD K.K., Japan
  • Junko  Sato, PhD
    Junko Sato, PhD Office Director, Office of International Cooperation
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Load More

Contact us

Please contact the DIA Japan office in Tokyo for further information.

Tel: +81-3-6214-0574
Fax: +81-3-3278-1313
Japan@DIAglobal.org
www.diajapan.org